Literature DB >> 1911216

Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

J A Henry1, M K Bennett, N H Piggott, D L Levett, F E May, B R Westley.   

Abstract

The pNR-2/pS2 protein is regulated by oestrogens in breast cancer cell lines. This report describes a systematic survey of pNR-2/pS2 expression in a number of common epithelial tumours. Expression was evaluated immunohistochemically in an archival series using antisera raised against the C-terminus of the pNR-2/pS2 protein. Expression of pNR-2/pS2 by malignant epithelial tumours was widespread. Intense immunohistochemical staining was found in tumour cells in a proportion of pancreatic (6/8), large intestinal (7/12), gastric (9/16) and endometrial (4/12) carcinomas. Positive staining for the pNR-2/pS2 protein was also found in both benign and malignant ovarian epithelial tumours and was very significantly associated with mucinous differentiation (P less than 0.00001). Small numbers of carcinomas of bladder (2/10) and prostate (2/7) showed less intense staining and single examples of cervical carcinoma (1/7) and lung carcinoma (1/19) stained positively. None of the renal carcinomas (0/16) examined stained positively. Positive staining showed no correlation with gender. Although there are reports of oestrogen receptor expression in most of the tumour types considered, the possibility of other regulatory influences must also be considered. The pNR-2/pS2 protein may well have a more general role in human epithelial neoplasia than hitherto realised.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911216      PMCID: PMC1977697          DOI: 10.1038/bjc.1991.380

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells.

Authors:  F E May; B R Westley
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

2.  The prognostic importance of steroid receptors in endometrial carcinoma.

Authors:  D C Palmer; I M Muir; A I Alexander; M Cauchi; R C Bennett; M A Quinn
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

3.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.

Authors:  M C Rio; J P Bellocq; J Y Daniel; C Tomasetto; R Lathe; M P Chenard; A Batzenschlager; P Chambon
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

4.  Expression of the pS2 gene in normal, benign and neoplastic human stomach.

Authors:  Y Luqmani; C Bennett; I Paterson; C M Corbishley; M C Rio; P Chambon; G Ryall
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

5.  Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry.

Authors:  N H Piggott; J A Henry; F E May; B R Westley
Journal:  J Pathol       Date:  1991-02       Impact factor: 7.996

6.  Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.

Authors:  A Bizzi; A M Codegoni; F Landoni; G Marelli; S Marsoni; A M Spina; W Torri; C Mangioni
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

7.  Estrogen and progesterone receptors in gastric cancer.

Authors:  A Tokunaga; K Nishi; N Matsukura; N Tanaka; M Onda; A Shirota; G Asano; K Hayashi
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

8.  [Specific expression of human pS2 gene in breast cancer].

Authors:  M C Rio; J P Bellocq; B Gairard; C Koehl; R Renaud; P Chambon
Journal:  Biochimie       Date:  1988-07       Impact factor: 4.079

9.  The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.

Authors:  A M Nunez; M Berry; J L Imler; P Chambon
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

10.  pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

Authors:  J A Henry; N H Piggott; U K Mallick; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  28 in total

Review 1.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

2.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans.

Authors:  Mohammed Soutto; Abbes Belkhiri; M Blanca Piazuelo; Barbara G Schneider; Dunfa Peng; Aixiang Jiang; M Kay Washington; Yasin Kokoye; Sheila E Crowe; Alexander Zaika; Pelayo Correa; Richard M Peek; Wael El-Rifai
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

4.  Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas.

Authors:  H Uchino; H Kataoka; H Itoh; M Koono
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

5.  Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo.

Authors:  M B Resnick; E Sabo; P A Meitner; S S Kim; Y Cho; H K Kim; R Tavares; S F Moss
Journal:  Gut       Date:  2006-04-26       Impact factor: 23.059

6.  Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements.

Authors:  H Itoh; N Inoue; D K Podolsky
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

7.  Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha.

Authors:  M P Ebert; J Hoffmann; C Haeckel; K Rutkowski; R M Schmid; M Wagner; G Adler; H U Schulz; A Roessner; W Hoffmann; P Malfertheiner
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

8.  Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases.

Authors:  I Soubeyran; J Wafflart; F Bonichon; I de Mascarel; M Trojani; M Durand; A Avril; J M Coindre
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

9.  cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis.

Authors:  H Itoh; M Tomita; H Uchino; T Kobayashi; H Kataoka; R Sekiya; Y Nawa
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.

Authors:  Steven F Moss; Jin-Woo Lee; Edmond Sabo; Anna K Rubin; John Rommel; Bruce R Westley; Felicity E B May; John Gao; Patricia A Meitner; Rose Tavares; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.